European Journal of Pharmacology · 2023 · 19 citations · 25 references
Life SciencesOncologyPharmacologyAutophagyCell SignalingSignal TransductionAutophagy DysregulationAutophagy In CancerAutophagy ModulationAutophagy RegulationAutophagy Signaling PathwaysHepatocellular CarcinomaAlpha-fetoprotein BiomarkerAutophagy In Cancer MetabolismCancer-associated AutophagyComplement Receptor SignalingHepatocellular Carcinoma PathogenesisOncogenic Autophagy
Hepatocellular carcinoma (HCC) is highly refractory. β-Sitosterol has been reported to suppress proliferation and migration as well as interfere with cell metabolism in tumors. However, there is limited information on the effects of β-sitosterol on HCC. Herein, we used a xenograft mouse model to investigate the effects of β-sitosterol on HCC tumor growth. The molecular mechanism was elucidated using quantitative real-time PCR, western blotting, lentiviral transfection, CCK8, scratch, Transwell, and Ad-mCherry-GFP-LC3B assays. The results showed that HepG2 cells highly expressed complement C5a receptor 1. β-Sitosterol antagonized complement component 5a and exerted inhibitory effects on the proliferation and migration of HepG2 cells. The inhibitory effect of β-sitosterol was reversed by the knockdown of complement C5a receptor 1. Bioinformatics analysis suggested alpha fetoprotein (AFP) as a downstream factor of complement C5a receptor 1. β-Sitosterol inhibited AFP expression, which was reversed by complement C5a receptor 1 knockdown. The inhibitory effects of β-sitosterol on cell proliferation and migration were weakened by AFP overexpression. Furthermore, β-sitosterol induced autophagy in HepG2 cells, which was reversed by complement C5a receptor 1 knockdown and AFP overexpression. Blockade of autophagy by 3-MA attenuated β-sitosterol inhibition of proliferation and migration in HepG2 cells. Moreover, β-sitosterol inhibited HCC progression in vivo. Our findings demonstrate that β-sitosterol inhibits HCC advancement by activating autophagy through the complement C5a receptor 1/AFP axis. These findings recommend β-sitosterol as a promising therapy for HCC.
25
Rebecca L. Siegel, Kimberly D. Miller, Hannah E. Fuchs et al. · CA A Cancer Journal for Clinicians · 2022 · 18.2K citations · Full text
Annual report to the nation on the status of cancer, part I: National cancer statistics
S. Jane Henley, Elizabeth Ward, Susan Scott et al. · Cancer · 2020 · 896 citations · Full text
Xin‐Fei Xu, Hao Xing, Jun Han et al. · JAMA Surgery · 2018 · 540 citations · Full text
Autophagy maintains tumour growth through circulating arginine
Laura Poillet-Perez, Xiaoqi Xie, Le Zhan et al. · Nature · 2018 · 377 citations